EDN1 and neoplasm: Following treatment with OXP (10 μM, 24 h), a generalized elevation of EDN1 mRNA expression levels was observed in colorectal cancer (CRC) tumor cells, with OXP-sensitive cell lines (e.g., HCT8) exhibiting a more pronounced upregulation of EDN1 expression (Fig. 2F).